Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
34.64
-0.07 (-0.20%)
Aug 31, 2026, 4:00 PM EDT - Market closed
Roivant Sciences Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Roivant Sciences stock has a consensus rating of "Strong Buy" and an average price target of $41.82. The average 1-year stock price forecast is 20.73% higher than the current stock price, while the lowest is $37 (+6.81%) and the highest is $50 (+44.34%).
Price Target: $41.82 (+20.73%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Roivant Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 10 | 9 | 9 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $40 | Buy | Maintains | $40 | +15.47% | Aug 28, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $41 | Buy | Reiterates | $41 | +18.36% | Aug 28, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Reiterates $37 → $38 | Hold | Reiterates | $37 → $38 | +8.26% | Aug 28, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $42 | Buy | Maintains | $42 | +21.25% | Aug 18, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $40 | Buy | Maintains | $40 | +15.47% | Aug 10, 2026 |
Financial Forecast
Revenue This Year
50.63M
from 8.26M
Increased by 512.98%
Revenue Next Year
390.65M
from 50.63M
Increased by 671.54%
EPS This Year
-1.58
from -1.08
EPS Next Year
-1.72
from -1.58
EPS and Forward PE are based on non-GAAP adjusted numbers.